CSPC Pharmaceutical Group Limited. 

$1.05
46
+$0+0% Friday 13:30

Statistics

Day High
1.05
Day Low
1.05
52W High
1.39
52W Low
0.62
Volume
-
Avg. Volume
-
Mkt Cap
12.09B
P/E Ratio
27.8
Dividend Yield
3.54%
Dividend
0.04

Upcoming

Dividends

3.54%Dividend Yield
Nov 25
$0.02
Jul 25
$0.01
Nov 24
$0.02
Jun 24
$0.02
Oct 23
$0.02
10Y Growth
15.43%
5Y Growth
11.18%
3Y Growth
5.24%
1Y Growth
20.81%

Earnings

25MarExpected
Q2 2022
Q3 2022
Q4 2023
Q2 2024
Q1 2025
Q2 2025
Q4 2025
0.12
0.16
0.2
0.24
Expected EPS
N/A
Actual EPS
N/A

Financials

14.92%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
7.96BRevenue
1.19BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHJTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG is a major player in the pharmaceutical industry, directly competing with CSPC in various therapeutic areas, including oncology and immunology.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. competes globally in the pharmaceutical sector, offering a wide range of products that overlap with CSPC's portfolio, especially in the development of innovative drugs and vaccines.
Novartis
NVS
Mkt Cap279.67B
Novartis AG is a global healthcare company that competes with CSPC Pharmaceutical in areas such as research, development, manufacturing, and marketing of pharmaceuticals.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is a leading pharmaceutical company that competes with CSPC in developing and marketing drugs in various therapeutic areas, including cancer and infectious diseases.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline plc is a global healthcare company that competes with CSPC in the pharmaceutical and healthcare sector, particularly in the development of vaccines and medications.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. competes with CSPC in the biopharmaceutical field, focusing on developing drugs for conditions such as autoimmune diseases and cancer.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with CSPC in the global pharmaceutical market, focusing on areas such as diabetes solutions, human vaccines, and innovative drugs.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb Company is a global biopharmaceutical company competing with CSPC in the discovery, development, and delivery of medicines in areas like cancer and cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company that competes with CSPC in developing and commercializing prescription medicines for several major disease areas.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson is a diversified healthcare giant that competes with CSPC Pharmaceutical across a broad range of therapeutic areas and products, including pharmaceuticals and biotechnology.

About

There is no Profile data available for CVG.SG.
Show more...
CEO
Mr. Dongchen Cai
Employees
21400
Country
Hong Kong
ISIN
HK1093012172

Listings

0 Comments

Share your thoughts

FAQ

What is CSPC Pharmaceutical Group Limited. stock price today?
The current price of CHJTF is $1.05 USD — it has increased by +0% in the past 24 hours. Watch CSPC Pharmaceutical Group Limited. stock price performance more closely on the chart.
What is CSPC Pharmaceutical Group Limited. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange CSPC Pharmaceutical Group Limited. stocks are traded under the ticker CHJTF.
Is CSPC Pharmaceutical Group Limited. stock price growing?
CHJTF stock has risen by +0% compared to the previous week, the month change is a +2.94% rise, over the last year CSPC Pharmaceutical Group Limited. has showed a +64.06% increase.
What is CSPC Pharmaceutical Group Limited. market cap?
Today CSPC Pharmaceutical Group Limited. has the market capitalization of 12.09B
When is the next CSPC Pharmaceutical Group Limited. earnings date?
CSPC Pharmaceutical Group Limited. is going to release the next earnings report on August 26, 2026.
What is CSPC Pharmaceutical Group Limited. revenue for the last year?
CSPC Pharmaceutical Group Limited. revenue for the last year amounts to 7.96B USD.
What is CSPC Pharmaceutical Group Limited. net income for the last year?
CHJTF net income for the last year is 1.19B USD.
Does CSPC Pharmaceutical Group Limited. pay dividends?
Yes, CHJTF dividends are paid semi-annual. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 3.54%.
How many employees does CSPC Pharmaceutical Group Limited. have?
As of May 06, 2026, the company has 21,400 employees.
In which sector is CSPC Pharmaceutical Group Limited. located?
CSPC Pharmaceutical Group Limited. operates in the Health & Wellness sector.
When did CSPC Pharmaceutical Group Limited. complete a stock split?
The last stock split for CSPC Pharmaceutical Group Limited. was on October 15, 2020 with a ratio of 8:5.
Where is CSPC Pharmaceutical Group Limited. headquartered?
CSPC Pharmaceutical Group Limited. is headquartered in Shijiazhuang, Hong Kong.